News Related to Iron Deficiency Anemia

Related coverage linked through entity extraction aliases.

EMA Approves Shield Therapeutics' FeRACCRU for Adolescents Following FDA Pediatric Authorization

Mar 31, 2026

The European Medicines Agency has approved Shield Therapeutics' FeRACCRU® for adolescents aged 12 and older, following FDA approval of ACCRUFeR® for children 10+. The expansion was supported by Phase 3 pediatric trial data showing efficacy and safety in children as young as 1 month.

Half of Americans Unaware of At-Home Colorectal Cancer Screening Options

Mar 05, 2026

A nationwide survey reveals 50% of Americans don't know colorectal cancer can be screened at home, as the disease becomes the leading cause of cancer death in adults under 50. Current guidelines recommend screening begin at age 45.